Influenza pandemic planning and performance in Canada, 2009.
Identifieur interne : 000C93 ( Main/Exploration ); précédent : 000C92; suivant : 000C94Influenza pandemic planning and performance in Canada, 2009.
Auteurs : Alan P. Kendal [États-Unis] ; Noni E. MacdonaldSource :
- Canadian journal of public health = Revue canadienne de sante publique [ 0008-4263 ]
Descripteurs français
- KwdFr :
- Administration de la santé publique (), Canada (épidémiologie), Coopération internationale, Flambées de maladies (), Grippe humaine (), Grippe humaine (épidémiologie), Humains, Planification en santé (), Planification en santé (organisation et administration), Sous-type H1N1 du virus de la grippe A, Vaccins antigrippaux (administration et posologie), Vaccins antigrippaux (ressources et distribution).
- MESH :
- administration et posologie : Vaccins antigrippaux.
- organisation et administration : Planification en santé.
- ressources et distribution : Vaccins antigrippaux.
- épidémiologie : Canada, Grippe humaine.
- Administration de la santé publique, Coopération internationale, Flambées de maladies, Grippe humaine, Humains, Planification en santé, Sous-type H1N1 du virus de la grippe A.
- Wicri :
- geographic : Canada.
English descriptors
- KwdEn :
- Canada (epidemiology), Disease Outbreaks (prevention & control), Health Planning (methods), Health Planning (organization & administration), Humans, Influenza A Virus, H1N1 Subtype, Influenza Vaccines (administration & dosage), Influenza Vaccines (supply & distribution), Influenza, Human (epidemiology), Influenza, Human (prevention & control), International Cooperation, Public Health Administration (methods).
- MESH :
- chemical , administration & dosage : Influenza Vaccines.
- geographic , epidemiology : Canada.
- epidemiology : Influenza, Human.
- methods : Health Planning, Public Health Administration.
- organization & administration : Health Planning.
- prevention & control : Disease Outbreaks, Influenza, Human.
- chemical , supply & distribution : Influenza Vaccines.
- Humans, Influenza A Virus, H1N1 Subtype, International Cooperation.
Abstract
This commentary evaluates Canadian actions following identification of pH1N1 influenza virus in 2009. We also report on some international issues affecting vaccine manufacture, and compare pH1N1 influenza vaccination programs in several industrialized countries. WHO's pandemic declaration was the trigger for Canada to take the following steps: (1) implement its sole source pandemic vaccine supply contract, (2) use an alternate, internationally-developed approach to authorize emergency use of adjuvant-containing vaccine not yet fully approved in Canada, (3) release stocks of antiviral, and (4) develop many health-related policies, through committees other than those normally used outside a pandemic. We note key successes and challenges in these steps, and suggest responses to two priority issues: first, improve planning for surges in demand for the clinical services that represent the main way in which severe disease impact was reduced, and second, establish from the outset of Public Health planning that immunization programs will phase use of vaccine in different target groups, as done elsewhere, reflecting realistic vaccine delivery rates and the likely early occurrence of the main epidemic wave.
PubMed: 21370779
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Influenza pandemic planning and performance in Canada, 2009.</title><author><name sortKey="Kendal, Alan P" sort="Kendal, Alan P" uniqKey="Kendal A" first="Alan P" last="Kendal">Alan P. Kendal</name><affiliation wicri:level="2"><nlm:affiliation>Rollins School of Public Health, Emory University, Atlanta, GA, USA. kendal2@shaw.ca</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Rollins School of Public Health, Emory University, Atlanta, GA</wicri:regionArea><placeName><region type="state">Géorgie (États-Unis)</region></placeName></affiliation></author><author><name sortKey="Macdonald, Noni E" sort="Macdonald, Noni E" uniqKey="Macdonald N" first="Noni E" last="Macdonald">Noni E. Macdonald</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="????"><PubDate><MedlineDate>2010 Nov-Dec</MedlineDate></PubDate></date><idno type="RBID">pubmed:21370779</idno><idno type="pmid">21370779</idno><idno type="wicri:Area/Main/Corpus">000548</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000548</idno><idno type="wicri:Area/Main/Curation">000548</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000548</idno><idno type="wicri:Area/Main/Exploration">000548</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Influenza pandemic planning and performance in Canada, 2009.</title><author><name sortKey="Kendal, Alan P" sort="Kendal, Alan P" uniqKey="Kendal A" first="Alan P" last="Kendal">Alan P. Kendal</name><affiliation wicri:level="2"><nlm:affiliation>Rollins School of Public Health, Emory University, Atlanta, GA, USA. kendal2@shaw.ca</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Rollins School of Public Health, Emory University, Atlanta, GA</wicri:regionArea><placeName><region type="state">Géorgie (États-Unis)</region></placeName></affiliation></author><author><name sortKey="Macdonald, Noni E" sort="Macdonald, Noni E" uniqKey="Macdonald N" first="Noni E" last="Macdonald">Noni E. Macdonald</name></author></analytic><series><title level="j">Canadian journal of public health = Revue canadienne de sante publique</title><idno type="ISSN">0008-4263</idno></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Canada (epidemiology)</term><term>Disease Outbreaks (prevention & control)</term><term>Health Planning (methods)</term><term>Health Planning (organization & administration)</term><term>Humans</term><term>Influenza A Virus, H1N1 Subtype</term><term>Influenza Vaccines (administration & dosage)</term><term>Influenza Vaccines (supply & distribution)</term><term>Influenza, Human (epidemiology)</term><term>Influenza, Human (prevention & control)</term><term>International Cooperation</term><term>Public Health Administration (methods)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Administration de la santé publique ()</term><term>Canada (épidémiologie)</term><term>Coopération internationale</term><term>Flambées de maladies ()</term><term>Grippe humaine ()</term><term>Grippe humaine (épidémiologie)</term><term>Humains</term><term>Planification en santé ()</term><term>Planification en santé (organisation et administration)</term><term>Sous-type H1N1 du virus de la grippe A</term><term>Vaccins antigrippaux (administration et posologie)</term><term>Vaccins antigrippaux (ressources et distribution)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Canada</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Vaccins antigrippaux</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Health Planning</term><term>Public Health Administration</term></keywords><keywords scheme="MESH" qualifier="organisation et administration" xml:lang="fr"><term>Planification en santé</term></keywords><keywords scheme="MESH" qualifier="organization & administration" xml:lang="en"><term>Health Planning</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Disease Outbreaks</term><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="ressources et distribution" xml:lang="fr"><term>Vaccins antigrippaux</term></keywords><keywords scheme="MESH" type="chemical" qualifier="supply & distribution" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Canada</term><term>Grippe humaine</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Humans</term><term>Influenza A Virus, H1N1 Subtype</term><term>International Cooperation</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Administration de la santé publique</term><term>Coopération internationale</term><term>Flambées de maladies</term><term>Grippe humaine</term><term>Humains</term><term>Planification en santé</term><term>Sous-type H1N1 du virus de la grippe A</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Canada</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">This commentary evaluates Canadian actions following identification of pH1N1 influenza virus in 2009. We also report on some international issues affecting vaccine manufacture, and compare pH1N1 influenza vaccination programs in several industrialized countries. WHO's pandemic declaration was the trigger for Canada to take the following steps: (1) implement its sole source pandemic vaccine supply contract, (2) use an alternate, internationally-developed approach to authorize emergency use of adjuvant-containing vaccine not yet fully approved in Canada, (3) release stocks of antiviral, and (4) develop many health-related policies, through committees other than those normally used outside a pandemic. We note key successes and challenges in these steps, and suggest responses to two priority issues: first, improve planning for surges in demand for the clinical services that represent the main way in which severe disease impact was reduced, and second, establish from the outset of Public Health planning that immunization programs will phase use of vaccine in different target groups, as done elsewhere, reflecting realistic vaccine delivery rates and the likely early occurrence of the main epidemic wave.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">21370779</PMID><DateCompleted><Year>2011</Year><Month>04</Month><Day>19</Day></DateCompleted><DateRevised><Year>2020</Year><Month>02</Month><Day>05</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0008-4263</ISSN><JournalIssue CitedMedium="Print"><Volume>101</Volume><Issue>6</Issue><PubDate><MedlineDate>2010 Nov-Dec</MedlineDate></PubDate></JournalIssue><Title>Canadian journal of public health = Revue canadienne de sante publique</Title><ISOAbbreviation>Can J Public Health</ISOAbbreviation></Journal><ArticleTitle>Influenza pandemic planning and performance in Canada, 2009.</ArticleTitle><Pagination><MedlinePgn>447-53</MedlinePgn></Pagination><Abstract><AbstractText>This commentary evaluates Canadian actions following identification of pH1N1 influenza virus in 2009. We also report on some international issues affecting vaccine manufacture, and compare pH1N1 influenza vaccination programs in several industrialized countries. WHO's pandemic declaration was the trigger for Canada to take the following steps: (1) implement its sole source pandemic vaccine supply contract, (2) use an alternate, internationally-developed approach to authorize emergency use of adjuvant-containing vaccine not yet fully approved in Canada, (3) release stocks of antiviral, and (4) develop many health-related policies, through committees other than those normally used outside a pandemic. We note key successes and challenges in these steps, and suggest responses to two priority issues: first, improve planning for surges in demand for the clinical services that represent the main way in which severe disease impact was reduced, and second, establish from the outset of Public Health planning that immunization programs will phase use of vaccine in different target groups, as done elsewhere, reflecting realistic vaccine delivery rates and the likely early occurrence of the main epidemic wave.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kendal</LastName><ForeName>Alan P</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Rollins School of Public Health, Emory University, Atlanta, GA, USA. kendal2@shaw.ca</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>MacDonald</LastName><ForeName>Noni E</ForeName><Initials>NE</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Can J Public Health</MedlineTA><NlmUniqueID>0372714</NlmUniqueID><ISSNLinking>0008-4263</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002170" MajorTopicYN="N" Type="Geographic">Canada</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006285" MajorTopicYN="N">Health Planning</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000458" MajorTopicYN="Y">organization & administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053118" MajorTopicYN="N">Influenza A Virus, H1N1 Subtype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName><QualifierName UI="Q000600" MajorTopicYN="Y">supply & distribution</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007391" MajorTopicYN="N">International Cooperation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011635" MajorTopicYN="N">Public Health Administration</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>3</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>3</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>4</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21370779</ArticleId><ArticleId IdType="pmc">PMC6973708</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>CMAJ. 2010 Feb 23;182(3):257-64</Citation><ArticleIdList><ArticleId IdType="pubmed">20093297</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 1999 Mar-Apr;5(2):195-203</Citation><ArticleIdList><ArticleId IdType="pubmed">10221870</ArticleId></ArticleIdList></Reference><Reference><Citation>MMWR Recomm Rep. 2009 Aug 28;58(RR-10):1-8</Citation><ArticleIdList><ArticleId IdType="pubmed">19713882</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Curr. 2010 Feb 24;2:RRN1148</Citation><ArticleIdList><ArticleId IdType="pubmed">20191082</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2009 Nov 4;302(17):1872-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19822627</ArticleId></ArticleIdList></Reference><Reference><Citation>MMWR Morb Mortal Wkly Rep. 2010 Apr 2;59(12):363-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20360670</ArticleId></ArticleIdList></Reference><Reference><Citation>MMWR Morb Mortal Wkly Rep. 2009 Apr 24;58(15):400-2</Citation><ArticleIdList><ArticleId IdType="pubmed">19390508</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2010 Jun 03;340:c2912</Citation><ArticleIdList><ArticleId IdType="pubmed">20525679</ArticleId></ArticleIdList></Reference><Reference><Citation>CMAJ. 2010 Jan 12;182(1):39-44</Citation><ArticleIdList><ArticleId IdType="pubmed">19926677</ArticleId></ArticleIdList></Reference><Reference><Citation>Wkly Epidemiol Rec. 2009 Jun 5;84(23):213-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19499605</ArticleId></ArticleIdList></Reference><Reference><Citation>CMAJ. 2010 Mar 9;182(4):349-55</Citation><ArticleIdList><ArticleId IdType="pubmed">20159893</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>États-Unis</li></country><region><li>Géorgie (États-Unis)</li></region></list><tree><noCountry><name sortKey="Macdonald, Noni E" sort="Macdonald, Noni E" uniqKey="Macdonald N" first="Noni E" last="Macdonald">Noni E. Macdonald</name></noCountry><country name="États-Unis"><region name="Géorgie (États-Unis)"><name sortKey="Kendal, Alan P" sort="Kendal, Alan P" uniqKey="Kendal A" first="Alan P" last="Kendal">Alan P. Kendal</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/GrippeCanadaV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000C93 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000C93 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= GrippeCanadaV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:21370779
|texte= Influenza pandemic planning and performance in Canada, 2009.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:21370779" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeCanadaV3
| This area was generated with Dilib version V0.6.35. |  |